Accession Number: | 0001179110-20-007590 |
Date: | 2020-06-18 |
Issuer: | CELLDEX THERAPEUTICS, INC. (CLDX) |
Original Submission Date: |
MARUCCI ANTHONY S
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD
HAMPTON, NJ 08827
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
INCENTIVE STOCK OPTION (RIGHT TO BUY) | 10.38 | 2020-06-18 | deemed execution date | A | 245,000 (a) | 2021-06-18 | 2030-06-18 | common stock 245,000 | $10.38 | 245,000 | direct |
ID | footnote |
---|---|
f1 | represents option granted by the issuer pursuant to its 2008 stock option and incentive plan. |
f2 | 25% vest on june 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. |